PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $626,000 | +12.8% | 88,700 | 0.0% | 0.00% | – |
Q4 2020 | $555,000 | +13.3% | 88,700 | -2.1% | 0.00% | – |
Q3 2020 | $490,000 | +13.7% | 90,600 | +9.8% | 0.00% | – |
Q2 2020 | $431,000 | +106.2% | 82,500 | +24.4% | 0.00% | – |
Q1 2020 | $209,000 | -57.5% | 66,300 | -45.7% | 0.00% | – |
Q4 2019 | $492,000 | -6.6% | 122,000 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $527,000 | +14.6% | 122,000 | +5.8% | 0.00% | 0.0% |
Q2 2019 | $460,000 | -25.6% | 115,300 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $618,000 | +4.6% | 115,300 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $591,000 | -49.6% | 115,300 | -4.6% | 0.00% | -50.0% |
Q3 2018 | $1,173,000 | -4.5% | 120,906 | +0.4% | 0.00% | 0.0% |
Q2 2018 | $1,228,000 | -21.5% | 120,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,565,000 | – | 120,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |